J.M. Hartwell’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$501K Hold
19,400
0.09% 58
2019
Q2
$495K Sell
19,400
-1,400
-7% -$34.6K 0.09% 58
2019
Q1
$544K Buy
20,800
+1,400
+7% +$34.4K 0.1% 47
2018
Q4
$447K Sell
19,400
-1,400
-7% -$31.1K 0.09% 53
2018
Q3
$490K Hold
20,800
0.09% 63
2018
Q2
$480K Hold
20,800
0.09% 60
2018
Q1
$512K Hold
20,800
0.1% 60
2017
Q4
$558K Hold
20,800
0.1% 58
2017
Q3
$501K Hold
20,800
0.1% 61
2017
Q2
$446K Hold
20,800
0.09% 66
2017
Q1
$357K Sell
20,800
-800
-4% -$13.9K 0.08% 79
2016
Q4
$387K Hold
21,600
0.1% 67
2016
Q3
$449K Hold
21,600
0.11% 63
2016
Q2
$581K Hold
21,600
0.15% 48
2016
Q1
$585K Sell
21,600
-2,000
-8% -$53.6K 0.14% 49
2015
Q4
$685K Hold
23,600
0.16% 44
2015
Q3
$640K Hold
23,600
0.15% 46
2015
Q2
$646K Hold
23,600
0.14% 52
2015
Q1
$630K Buy
23,600
+600
+3% +$13.8K 0.14% 48
2014
Q4
$487K Hold
23,000
0.11% 61
2014
Q3
$548K Hold
23,000
0.13% 58
2014
Q2
$531K Hold
23,000
0.11% 63
2014
Q1
$525K Buy
23,000
+2,000
+10% +$42.6K 0.11% 60
2013
Q4
$388K Buy
21,000
+1,000
+5% +$17.4K 0.08% 74
2013
Q3
$338K Hold
20,000
0.08% 85
2013
Q2
$310K Buy
+20,000
New +$333K 0.08% 79

Other funds holding NVO

J.M. Hartwell's NVO Position: Q3 2019 in Review

J.M. Hartwell held its Novo Nordisk (NVO) position steady in Q3 2019 at 19,400 shares worth $501K. The position accounts for 0.09% of the portfolio, ranked #58.

J.M. Hartwell first reported a position in NVO in Q2 2013 and has held it in 26 quarters since. The position peaked at $685K in Q4 2015. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • J.M. Hartwell held 19,400 shares of Novo Nordisk worth $501K as of Q3 2019.
  • J.M. Hartwell left its Novo Nordisk share count unchanged in Q3 2019.
  • Novo Nordisk made up 0.09% of J.M. Hartwell's portfolio in Q3 2019, its #58 holding.
  • J.M. Hartwell first reported a position in Novo Nordisk in Q2 2013 and has held it in 26 quarters since.
  • J.M. Hartwell's Novo Nordisk position peaked at $685K in Q4 2015.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on J.M. Hartwell's 13F filing for Q3 2019, filed 7 Oct 2019.